Risedronate sodium is a potent bisphosphonate drug used extensively for the treatment and prevention of osteoporosis in both men and women. By inhibiting osteoclast-mediated bone resorption, it plays a… Read more
![Chemical structure of Risedronate Related Compound B ([3,6-bis[(3-pyridinyl)methyl]-2,5-dihydroxy-2,5-dioxido-1,4,2,5-dio (1604632)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FRisedronate-Related-Compound-B-36-bis3-pyridinylmethyl-25-dihydroxy-25-dioxido-1425-dio-1604632.png&w=3840&q=75)














Risedronate sodium is a potent bisphosphonate drug used extensively for the treatment and prevention of osteoporosis in both men and women. By inhibiting osteoclast-mediated bone resorption, it plays a critical role in modulating bone metabolism. To ensure the safety and efficacy of pharmaceutical formulations, laboratories utilize our extensive selection of risedronate sodium reference standards, including pharmacopeial and non-pharmacopeial impurities, as well as stable isotope labelled compounds. These materials are essential for rigorous impurity profiling, accurate method development, and validation during the quality control of the active pharmaceutical ingredient. By providing high-quality reference materials for these specific related compounds, we support the analytical testing required to meet strict regulatory standards for this therapeutic class.